Pharmicell (005690) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.080x

Based on the latest financial reports, Pharmicell (005690) has a cash flow conversion efficiency ratio of 0.080x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.78 Billion ≈ $5.95 Million USD) by net assets (₩110.43 Billion ≈ $74.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 005690 market cap for the company's overall valuation and market capitalisation.

Pharmicell - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Pharmicell's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmicell Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmicell ranked by their cash flow conversion efficiency. Explore 005690 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ChoiceOne Financial Services Inc NASDAQ:COFS	0.030x
Bank Mestika Dharma Tbk JK:BBMD	0.018x
MMTEC Inc NASDAQ:MTC	-0.138x
Automotive Properties Real Estate Investment Trust TO:APR-UN	0.016x
Guangxi Fenglin Wood Industry Group Co Ltd SHG:601996	0.029x
Tadiran Hldg TA:TDRN	-0.153x
Jiangsu Baoli Asphalt SHE:300135	-0.022x
Chorus Aviation Inc TO:CHR	0.127x

Annual Cash Flow Conversion Efficiency for Pharmicell (2010–2024)

The table below shows the annual cash flow conversion efficiency of Pharmicell from 2010 to 2024. View 005690 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩86.44 Billion ≈ $58.58 Million	₩3.50 Billion ≈ $2.37 Million	0.040x	-72.46%
2023-12-31	₩80.40 Billion ≈ $54.48 Million	₩11.81 Billion ≈ $8.01 Million	0.147x	+42.35%
2022-12-31	₩76.66 Billion ≈ $51.95 Million	₩7.91 Billion ≈ $5.36 Million	0.103x	+226.26%
2021-12-31	₩63.87 Billion ≈ $43.28 Million	₩-5.22 Billion ≈ $-3.54 Million	-0.082x	-152.00%
2020-12-31	₩57.11 Billion ≈ $38.70 Million	₩8.98 Billion ≈ $6.08 Million	0.157x	+10828.39%
2019-12-31	₩51.52 Billion ≈ $34.91 Million	₩-75.50 Million ≈ $-51.16K	-0.001x	-102.04%
2018-12-31	₩47.49 Billion ≈ $32.18 Million	₩3.40 Billion ≈ $2.31 Million	0.072x	+300.00%
2017-12-31	₩55.99 Billion ≈ $37.95 Million	₩-2.01 Billion ≈ $-1.36 Million	-0.036x	-442.90%
2016-12-31	₩94.60 Billion ≈ $64.11 Million	₩988.97 Million ≈ $670.21K	0.010x	+132.06%
2013-12-31	₩82.42 Billion ≈ $55.86 Million	₩-2.69 Billion ≈ $-1.82 Million	-0.033x	+72.09%
2012-12-31	₩101.58 Billion ≈ $68.84 Million	₩-11.87 Billion ≈ $-8.04 Million	-0.117x	+40.15%
2011-12-31	₩82.82 Billion ≈ $56.13 Million	₩-16.17 Billion ≈ $-10.96 Million	-0.195x	+77.02%
2010-12-31	₩9.90 Billion ≈ $6.71 Million	₩-8.41 Billion ≈ $-5.70 Million	-0.850x	--

About Pharmicell

KO:005690 Korea Biotechnology

Market Cap

$470.89 Million

₩694.85 Billion KRW

Market Cap Rank

#12656 Global

#358 in Korea

Share Price

₩11580.00

Change (1 day)

-0.43%

52-Week Range

₩8760.00 - ₩20250.00

All Time High

₩25150.00